Align Technology, Inc. vs InMode Ltd — how do they compare? Align Technology, Inc. trades at $179.9 (market cap $12.86B), while InMode Ltd trades at $15.33 (market cap $878.88M). The key difference: Align Technology, Inc. is far larger — about 14.6× InMode Ltd's market cap. Which is the better fit depends on your goals.
| ALGN | INMD | |
|---|---|---|
Market Cap | $12.86B | $878.88M |
Sector | Health | Technology |
52-Week High | $207.19 | $16.62 |
52-Week Low | $124.88 | $12.76 |
Enterprise Value | $11.92B | $346.55M |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
INMD trades at $15.28, up 1.8% on the day, with a bullish technical signal from moving averages and oscillators. The company reported a Q1 2026 earnings miss but maintains strong profitability with a 23.27% net income margin. Recent news includes an unsolicited acquisition proposal from Steel Partners at $16.75 per share, alongside ongoing securities fraud investigations announced in early July 2026.
The stock presents a mixed outlook; the acquisition offer and solid fundamentals suggest upside near the $16.50 consensus target, but legal scrutiny and earnings volatility pose significant risks. Investor sentiment is divided, with analysts evenly split between Buy and Hold ratings, reflecting uncertainty around the company's near-term trajectory.
Trailing returns across standard periods
Latest headlines on both assets
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →